GREY:TSTIF - Post by User
Comment by
binjo222on Oct 03, 2017 11:36am
158 Views
Post# 26770655
RE:RE:Rumbles Stumble
RE:RE:Rumbles Stumble Dr Wong, you've laid out a good overview of RR's accomplishments and shortcomings.
In addition, you noted the practical headwinds TSO3 faces; i.e. (a) buying sterilization equipment is not an 'impulse buy' for a hospital -- it takes time (b) J&J/Steris have a bigger footprint in the US than Getinge and (c) that J&J/Steris rely on price discounts, their installed base and product bundling to retain their customers. (Yes, the vendor already in-place has an advantage.)
But once the d-scopes are FDA certified for sterilization by the VP-4, hospital administrators face a dilema. If a patient is infected (perhaps killed) by a d-scope that was not sterilized when it could have been, the hospital will probably be held liable. (A recent court case has already held a hospital liable in a patient's death, as well as the OEM.)
In your opinion, at what point does legal liability start to move hospital administrators out of the 'comfort zone' they are now in? And at what point does legal liability prompt a hospital to move out of its scheduled replacement cycle for sterilizers?